Bram Verstockt

Gastroenterology — Universitair Ziekenhuis Leuven, Belgium

LeadR Profile

Bram Verstockt Universitair Ziekenhuis Leuven Belgium
2 598 ScienceLeadR Reputation 2598
Network Map

Gastroenterology

Subspecialties: Hepatology - Pharmacy - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Universitair Ziekenhuis Leuven

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapies.
cells, colitis, colon, eosinophils, biomarkers, inflammatory bowel diseases, therapeutics, tissues, colitis, ulcerative
J Crohns Colitis20260
REG3α is a Predictive Biomarker of Complicated Disease from Preclinical through Established Crohn's Disease.
cells, autophagy, serum, crohn disease, digestive system diseases, paneth cells, biomarkers, diagnosis
Clin Gastroenterol Hepatol20260
Positioning Guselkumab in The Treatment Algorithm for Ulcerative Colitis.
interleukin-23, colitis, safety, algorithms, therapeutics, colitis, ulcerative
J Inflamm Res20260
Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.
colitis, inflammatory bowel diseases, research, therapeutics, steroids, colitis, ulcerative
J Crohns Colitis20260
RELIEVE UCCD: one pathway, two diseases, and a glimpse into the future of IBD trial design.
liver diseases, gastrointestinal diseases
Lancet Gastroenterol Hepatol Top journal20260

Clinical Studies 25

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

Phase 2 11
N/A 5
Phase 3 4
Phase 1 2
Phase 4 2
Phase 2/Phase 3 1

By status:

Recruiting 10
Completed 6
Not yet recruiting 3
Unknown 3
Active not recruiting 2
Terminated 1

By type:

Interventional 24
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 0
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy and Safety of JNJ 78934804 in Participants With Moderately to Severely Active Crohn s Disease
2026-525922-39-00 — safety, crohn disease
Phase 3Not yet recruiting2026
Efficacy and Safety of JNJ 78934804 in Participants with Moderately to Severely Active Ulcerative Colitis
2026-525923-26-00 — colitis, safety, colitis, ulcerative
Phase 3Recruiting2026
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
2025-522001-38-00 — colitis, safety, crohn disease, multiple chronic conditions, inflammatory bowel diseases, therapeutics, colitis, ulcerative, pharmacokinetics
Phase 2Recruiting2026
Crohn s Head to Head Assessing Risankizumab Versus Guselkumab for One Year
2025-521590-13-00 — safety, crohn disease, therapeutics, head
Phase 3Recruiting2026
An Early Stage Study in Multiple Clinics of how Afimkibart May Affect the Body s Processing of Medicines that Rely on Cytochrome P450 Enzymes in Patients with Ulcerative Colitis
2025-524060-38-00 — cytochrome p-450 enzyme system, colitis, cytochromes, enzymes, colitis, ulcerative
Phase 1Not yet recruiting2026

LeadR Networks

Main global connection map